Steven Cohen’s BridgeBio Oncology BBOT Stock Holding History
Bought
Maintained
Sold
Other funds holding BBOT
Steven Cohen's BBOT Position: Q3 2026 in Review
Steven Cohen opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 29,570 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #3606 among its holdings. This is a return to the name: Steven Cohen previously reported a position in BBOT as recently as Q4 2025.
Steven Cohen first reported a position in BBOT in Q4 2025 and has held it in 2 quarters since. The position peaked at $295K in Q4 2025. 89 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.
- Steven Cohen held 29,570 shares of BridgeBio Oncology worth $121K as of Q3 2026.
- BridgeBio Oncology was a new Steven Cohen position in Q3 2026.
- BridgeBio Oncology made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3606 holding.
- Steven Cohen first reported a position in BridgeBio Oncology in Q4 2025 and has held it in 2 quarters since.
- Steven Cohen's BridgeBio Oncology position peaked at $295K in Q4 2025.
- 89 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.